A look at Baxter International Inc’s (BAX) recent performance gives investors their first glimpse of hope.

Baxter International Inc (NYSE: BAX) on Friday, plunged -1.69% from the previous trading day, before settling in for the closing price of $30.84. Within the past 52 weeks, BAX’s price has moved between $30.76 and $44.01.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 6.04%. The company achieved an average annual earnings per share of -29.69%. With a float of $506.57 million, this company’s outstanding shares have now reached $510.46 million.

Considering the fact that the conglomerate employs 60000 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 37.78%, operating margin of 4.46%, and the pretax margin is 1.19%.

Baxter International Inc (BAX) Insider Activity

Observing investor behavior towards Medical Instruments & Supplies industry stocks is more important than anything else. The insider ownership of Baxter International Inc is 0.79%, while institutional ownership is 93.73%. The most recent insider transaction that took place on Sep 16 ’24, was worth 39,046. Before that another transaction happened on Sep 13 ’24, when Company’s Officer proposed sale 16,063 for $39.81, making the entire transaction worth $639,465.

Baxter International Inc (BAX) Earnings and Forecasts

Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.49 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around -29.69% per share during the next fiscal year.

Baxter International Inc (NYSE: BAX) Trading Performance Indicators

Baxter International Inc (BAX) is currently performing well based on its current performance indicators. A quick ratio of 1.09 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.09. Likewise, its price to free cash flow for the trailing twelve months is 27.28.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.23, a number that is poised to hit 0.52 in the next quarter and is forecasted to reach 2.48 in one year’s time.

Technical Analysis of Baxter International Inc (BAX)

Compared to the last year’s volume of 4.11 million, its volume of 4.57 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 5.91%. Additionally, its Average True Range was 0.76.

During the past 100 days, Baxter International Inc’s (BAX) raw stochastic average was set at 2.54%, which indicates a significant decrease from 7.06% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 19.10% in the past 14 days, which was lower than the 27.90% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $34.52, while its 200-day Moving Average is $36.77. Nevertheless, the first resistance level for the watch stands at $30.73 in the near term. At $31.15, the stock is likely to face the second major resistance level. The third major resistance level sits at $31.49. If the price goes on to break the first support level at $29.98, it is likely to go to the next support level at $29.64. Should the price break the second support level, the third support level stands at $29.23.

Baxter International Inc (NYSE: BAX) Key Stats

Market capitalization of the company is 15.22 billion based on 510,588K outstanding shares. Right now, sales total 14,813 M and income totals 2,656 M. The company made 2,699 M in profit during its latest quarter, and 140,000 K in sales during its previous quarter.